To determine whether mineralocorticosteroids and glucocorticosteroids have specific effects on colonic electrolyte transport, we compared the effect of aldosterone and RU 28362, a glucocorticoid receptor-specific agonist that does not bind to the aldosterone receptor, on unidirectional Na, Cl, and K fluxes across isolated mucosa of the rat distal colon. Continuous infusion of aldosterone for 7 d produced changes in four specific transport processes: induction of both active electrogenic, amiloride-sensitive sodium absorption and active electrogenic potassium secretion, enhancement of active electroneutral potassium absorption, and inhibition of electroneutral Na-Cl absorption, the predominant transport process in this epithelium. In contrast, continuous infusion of RU 28362 for 1-11 d produced a sustained increase in electroneutral Na-Cl absorption. This glucocorticoid receptor-specific agonist did not induce electrogenic sodium absorption nor affect either potassium absorption or secretion. These studies demonstrate that aldosterone (i.e., mineralocorticoid) and glucocorticoid receptors modulate separate and specific changes in active sodium and potassium transport. These results suggest that other glucocorticoids (e.g., dexamethasone, methylprednisolone) are not glucocorticoid receptor-specific and that their effects on electrogenic sodium absorption and potassium transport most likely represent the binding of these agonists to the aldosterone receptor.
Introduction
Dietary sodium depletion results in significant changes in electrolyte transport in the distal colon of the rat (1) (2) (3) (4) . The primary effect seen in this model of secondary hyperaldosteronism is an induction of active amiloride-sensitive sodium transport and active electrogenic potassium secretion which are the changes usually observed in other aldosterone-responsive epithelia (1, 3) . However, dietary sodium depletion also affects electroneutral sodium and potassium absorption in the rat distal colon: electroneutral Na-Cl absorption is inhibited and electroneutral potassium absorption is stimulated (3, 5) . Recent studies with continuous infusion of aldosterone have confirmed that the changes in sodium and chloride transport observed in dietary sodium depletion are due to aldosterone (6) ; similar studies have not yet been performed for potassium transport. Synthetic glucocorticoids (e.g., dexamethasone, methylprednisolone) also produce substantial changes in both sodium and potassium movement in the mammalian distal colon (1, 3, 4, (7) (8) (9) (10) (11) (12) . Although both glucocorticoid and aldosterone (i.e., mineralocorticoid) receptors have been identified in the cytosol of colonic epithelial cells (13) (14) (15) (16) (17) , there has been considerable controversy whether separate and specific changes in ion transport are mediated by the activation of these glucocorticoid and mineralocorticoid receptors. Experiments with dexamethasone and methylprednisolone reveal that many (but not all) of the changes in electrolyte transport produced by these glucocorticoids are similar to those observed in dietary sodium depletion and after aldosterone infusion (1, 3, 7, 18) . However, in the absence ofcrossover binding of one corticosteroid to the opposite cystolic receptor, it is not known whether glucocorticoids and aldosterone produce distinct and unique changes in sodium and potassium transport.
Resolution of this question has been long hampered by the failure to appreciate, until recently, that most "pure" synthetic glucocorticoids (i.e., dexamethasone, methylprednisolone) also bind to the aldosterone receptor at doses that have been frequently employed in these experiments. The recent synthesis by Roussel UCLAF, a French pharmaceutical company, of a family of "ultrapure" glucocorticoids has provided an opportunity to delineate this problem in better detail (19). 1 1B, 1713-Dihydroxy-6-methyl-1 7a-( 1-propynyl) androsta-1,4,6-triene-3-one (RU 28362)' is such an ultrapure synthetic glucocorticoid, and has high affinity only for the glucocorticoid (not the aldosterone) receptor. In recent studies with this and related synthetic ultrapure glucocorticoids in adrenalectomized rats, Bastl (20) has concluded that these glucocorticoid receptorspecific agonists regulate basal sodium transport which in the rat distal colon is predominantly electroneutral sodium absorption. Since higher doses of dexamethasone, but not of the glucocorticoid receptor-specific agonist, induced amiloridesensitive, electrogenic sodium absorption, Bastl (20) speculated that, whenever glucocorticoids appear to stimulate electrogenic sodium absorption, it may be due to crossover binding of the glucocorticoid (i.e., dexamethasone, but not RU 28362) to the aldosterone receptor. Bastl based these conclusions on in vivo luminal perfusion studies that were performed 1. Abbreviations used in this paper: G, conductance; I,,, short-circuit current Jmscl, mucosal-to-serosal chloride movement; JmsNa, mucosalto-serosal sodium movement; Jnetc', net chloride absorption; JnftNa, net sodium absorption; JsmC', serosal-to-mucosal chloride movement; soon after adrenalectomy. Thus, these experiments were limited by an inability to assess directly the effect of ultrapure glucocorticoids on active sodium and potassium transport processes, and by the possible confounding issue of endogenous steroid release after anesthesia and surgery (21). This previous study did not address the question of the mechanism by which glucocorticoids affect electrolyte transport in the colon of animals with intact adrenal glands. As 
Results
Sodium and chloride transport. Table I presents the results of unidirectional and net sodium and chloride fluxes in both the control group and the 1-d and 74 steroid-infused groups. In the control group, net sodium absorption was equal to net chloride absorption and was significantly greater than the I4C.
Since the diuretic amiloride affects sodium absorption in normal and hyperaldosterone rats differently, the effect of 10 JM amiloride on ion transport was also determined. Fig. 1 presents the results of 10 giM amiloride on JnaNa and I4, in the several experimental groups. As previously presented, amiloride did not alter net Na absorption ( Fig. 1 A) , net Cl absorption (data not shown), or I4C ( Fig. 1 B) . These results are similar to those previously reported in the distal colon of normal rats (23) and are consistent with electroneutral Na-Cl absorption as the predominant sodium absorptive process in this epithelium.
The 4-d steroid-infused group comprised animals that received infusion of either aldosterone or an equivalent amount (Fig. 1) . In addition, the amiloride-insensitive component of JnetNa in the l-d aldosterone group was significantly greater than that in the control group (7.2±0.9 vs.
4.9±0.4 geq/h cm2; P < 0.05). In contrast, 10 ,gM amiloride had no effect on any parameter of ion transport in the RU 28362 group. groups. These results demonstrate that the long term effects of aldosterone and RU 28362 on sodium and chloride transport in the rat distal colon differ both qualitatively and quantitatively.
The effect of RU 28362 on sodium and chloride transport with time is illustrated in Fig. 2 . Infusion of RU 28362 for 1, 3, 7, and 11 d resulted in substantial stimulation of both JnetNa and JnetCI compared with the control group; however, the rate of net sodium and chloride absorption observed after 3, 7, and 11 d of RU 28362 infusion was not significantly greater than that observed after 1 d of steroid infusion. These results indicate that stimulation of electroneutral Na-Cl absorption by RU 28362 is rapid and is not time dependent.
Potassium transport. Table II which is similar to that previously reported by this laboratory (3, 5) . Aldosterone infused for 7 d resulted in induction of active potassium secretion (-0.49±0.08 jueq/h . cm2) as a result of a significant increase in JsmK. This effect of long-term aldosterone infusion on potassium transport in the distal colon of the rat is similar to that previously reported for prolonged dietary Na depletion (5) . In contrast, a 7-d infusion of RU 28362 had no effect on unidirectional or net potassium fluxes and indicates that this glucocorticoid receptor-specific agonist did not alter potassium transport in the distal colon of the rat.
Previous in vitro studies of potassium transport in the rat distal colon have established that dietary sodium depletion not only induces active potassium secretion but also stimulates active K absorption (1, 5, 24) . This stimulation of active K absorption can be demonstrated when the K secretory process in inhibited by one or more experimental maneuvers (e.g., removal of Na from the serosal bathing solution, or the addition of either ouabain or bumetanide to the serosal bathing solution [24] ). To determine whether aldosterone or RU 28362 also induced active K absorption unidirectional 42K 2. These results are virtually identical to previous studies of Na and Cl transport in both dietary Na-depleted animals and those that had received continuous infusion of aldosterone (3, 6) and have been interpreted to indicate that aldosterone both induces amiloride-sensitive electrogenic Na absorption and inhibits electroneutral Na-Cl absorption. Aeq/h * cm2). njK in the aldosterone animals after the addition ofserosal ouabain was greater than that observed in the control group (0.52±0.06 Aeq/h * cm2). In contrast, K transport in the RU 28362 group after ouabain addition was identical to that observed in the control group. In the 1-d aldosterone group, both active potassium secretion (-0.72±0.06 ueq/h * cm2) and, in the presence of serosal ouabain, active K absorption (0.88±0.12 Aeq/h * cm2) were observed. The rates of these two potassium transport processes were not significantly different than that in the 7-d aldosterone group.
Discussion
Present concepts of the regulation of electrolyte transport by corticosteroids have evolved substantially over recent years (1) . It is now well accepted that aldosterone stimulates active amiloride-sensitive sodium absorption and active potassium secretion in the distal colon of rat and rabbit (3) (4) (5) . Glucocor- ticosteroids have similar, but not identical effects on electrolyte transport in the mammalian colon (1, (7) (8) (9) (10) (11) (12) , and considerable uncertainty exists regarding the exact role of aldosterone and glucocorticoids in the regulation of colonic ion transport. The demonstration that both specific mineralocorticoid and glucocorticoid cytosolic receptors are present in the rat and rabbit colon is consistent with the interpretation that each cytosolic steroid receptor mediates specific ion transport processes (13) (14) (15) (16) . However, to date no study has convincingly demonstrated which corticosteroid receptor is specifically responsible for each of the several previously identified corticosteroid-induced changes in sodium and potassium transport. Recently a series of compounds has been synthesized by the French pharmaceutical company, Roussel UCLAF, which are well suited to identify the specific role ofthe two corticosteroid receptors (19). Binding studies with glucocorticoid receptor-specific agonists, designated RU 26988 and RU 28362, have demonstrated these agonists bind with high affinity to the glucocorticoid receptor, do not displace the binding of radiolabeled aldosterone from the aldosterone receptor, and are Control not displaced from the glucocorticoid receptor by aldosterone (16, 19) . These compounds, therefore, permit investigation of the specific role of the glucocorticoid receptor in mediating changes in colonic ion transport. Although four studies of colonic epithelial function have been reported to date with these agonists (16, 18, 20, 25) , none have identified the active electrolyte transport changes that occur when glucocorticoids are administered to nonadrenalectomized animals. In studies ofcolonic electrolyte movement in adrenalectomized rats in vivo, Bastl (20) has suggested that the glucocorticoid receptor regulated basal electroneutral sodium absorption. The major limitations of this study are that in vivo studies are not ideal to establish the presence of active potassium secretion and that these synthetic glucocorticoid receptor-specific agonists were administered as pulses during the initial 26-h period after general anesthesia for surgical adrenalectomy. Halevy et al. (25) reported that RU 28362 infused into rats for 24 h increased amiloride-insensitive Isc which may represent either active chloride secretion or amiloride-resistant, electrogenic sodium transport. The former has been shown to be stimulated by dexamethasone and methylprednisolone in rat distal colon (26) and rat ileum (27) , respectively, and the latter was recently described in the rabbit cecum (28) . Unfortunately, neither ion flux measurements nor ion replacement studies were performed to establish the basis for this increase in Isc. Electrophysiologic studies compared the effects of RU 28362, dexamethasone, and secondary hyperaldosteronism in the rat distal colon and concluded that the two steroid receptors mediate changes in sodium and potassium transport that differ both qualitatively and quantitatively and that dexamethasone activates both types of receptors (18) . Two limitations of this study were the absence of isotopic sodium and potassium flux measurements and the use of very large amounts of corticosteroids (approximately 10 times the estimated Km of the glucorticoid receptor and the amount used in the other studies [20, 25] and in the present study).
Continuous infusion of aldosterone via implanted Alzet osmotic minipumps produce identical changes in sodium and chloride transport as dietary sodium depletion (6 and Table I ). Long-term 7-d infusion of aldosterone resulted in both stimulation of electrogenic amiloride-sensitive sodium absorption and inhibition of electroneutral Na-Cl absorption which is the primary sodium transport system in normal animals. These studies further demonstrate that infusion of aldosterone produced identical changes in potassium transport compared to those that are observed in dietary sodium depleted animals: both 1-and 7-d infusion of aldosterone resulted in active potassium secretion (Table II) . When aldosterone-stimulated potassium secretion was inhibited by the addition of 1 mM serosal ouabain, electroneutral potassium absorption was also enhanced (Fig. 3) . The rate of the potassium absorptive process in the presence of ouabain in the aldosterone-infused animals was significantly greater than that observed in the control animals and, therefore, indicates that aldosterone not only induced active potassium secretion but also stimulated active electroneutral'potassium absorption.
Aldosterone infused for 1 d produced a modest (though significant) stimulation of electroneutral Na-Cl absorption, in addition to its induction of electrogenic sodium absorption.
We suggest that this transient enhancement of electroneutral Na-Cl absorption is a result ofthe binding of aldosterone to the glucocorticoid receptor since RU 28362 did not inhibit electroneutral Na-Cl absorption at any time up to 11 d (Fig. 2) and experiments with both aldosterone (3) and sodium repletion (29) indicate that inhibition ofelectroneutral Na-Cl absorption requires exposure to aldosterone for at least 48-72 h. We speculate that the stimulation of electroneutral Na-Cl absorption by aldosterone at 24 h is secondary to its binding to the glucocorticoid receptor3 but that at latter time points its inhibition which mediated by the aldosterone receptor is dominant over its enhancement by the glucocorticoid receptor.
The glucocorticoid receptor-specific agonist RU 28362 resulted in stimulation of electroneutral Na-Cl absorption which was observed as early as 24 h after its infusion (Fig. 2) . Although aldosterone both induced electrogenic sodium absorption and inhibited electroneutral Na-Cl absorption, there was no evidence of either induction of electrogenic sodium transport or inhibition of electroneutral Na-Cl absorption even after 11 d of infusion of RU 28362 (Fig. 2) . Studies of potassium transport also did not reveal any effect of RU 28362 on either potassium absorption or potassium secretion (Fig. 3) . These results are in marked contrast to the changes in sodium and potassium transport produced by aldosterone and indicate that the two corticosteroid receptors in the distal colon produce highly specific changes in electrolyte transport. This distinct separation of the action of RU 28362 and aldosterone on ion transport in this epithelia indicates that RU 28362 is a specific glucocorticoid receptor agonist and, as a consequence, implies that the changes in potassium and electrogenic sodium transport mediated by aldosterone are mediated solely as a result of aldosterone's binding to the mineralocorticoid receptor. Thus, the mineralocorticoid receptor mediates very specific changes in sodium and potassium transport in the rat distal colon while the glucocorticoid receptor mediates other sodium (but not potassium) transport processes.
The efficacy of corticosteroids in the therapy of inflammatory bowel disease has been recognized for 40 years. Originally, the usefulness of corticosteroids in these clinical conditions was assumed solely the result of their anti-inflammatory effect. Newer understanding of the role of corticosteroids in the regulation of colonic electrolyte transport has raised the possibility that the antidiarrheal action of these steroids in inflammatory bowel disease may also be related to their proabsorptive effect on electrolyte movement (1, 29) . The results of this present study together with the recent demonstration that sodium and chloride are actively absorbed throughout the normal human colon predominantly by electroneutral transport mechanisms (30) (31) (32) may have important therapeutic implications for inflammatory bowel disease. An ultrapure glucocorticoid receptor-specific agonist such as RU 28362 may provide greater efficacy with fewer side effects than the presently used "glucocorticoids" which manifest significant mineralocorticoid agonist activity.
3. Since general anesthesia and abdominal surgery can result in elevation of plasma corticosterone levels (21), it is possible that the increase in electroneutral Na-Cl absorption observed after 24 h of aldosterone infusion is a result ofelevated endogenous corticosteroid levels and not of aldosterone. This possibility is unlikely since in animals subjected to considerably greater stress than the implantation of a subcutaneous minipump, plasma corticosterone levels had returned to normal within 14h(21).
